Skip to Content

Join the 'Breast Cancer - Adjuvant' group to help and get support from people like you.

Breast Cancer - Adjuvant News

Is Radiation Therapy Overused in Breast Cancer Care?

Posted 13 days ago by Drugs.com

TUESDAY, March 14, 2017 – More than half of older American women with early breast cancer may get more radiation therapy than needed, which significantly boosts medical costs, a new study indicates. Analyzing 2011 data on breast cancer patients, researchers estimated $164 million could have been saved by ordering a shorter radiation course. "Women who were eligible for shorter radiation courses or omission of radiation were still often receiving longer and more costly radiation courses," said study leader Dr. Rachel Greenup. She's an assistant professor of surgery at Duke University Medical Center Cancer Institute in Durham, N.C. However, Greenup and other experts said the study results might not be applicable to today because more women are receiving shorter courses of radiation than in 2011. For the study, Greenup's team used data on 43,000 breast cancer patients age 50 and older ... Read more

Related support groups: Cancer, Breast Cancer, Tamoxifen, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Nausea/Vomiting - Radiation Induced, Tamoxifen Hexal, Nolvadex, History - Radiation Therapy, Tamofen, Tamosin, Emblon, Soltamox, Tamone, Tamoxen, Genox, Nolvadex D

Soy Safe, Even Protective, for Breast Cancer Survivors

Posted 20 days ago by Drugs.com

TUESDAY, March 7, 2017 – The pros and cons of soy for breast cancer patients have been debated for years. Now, research involving more than 6,200 breast cancer survivors finds that those who ate the most soy had a lower risk of death from all causes during the nearly 10-year follow-up period. "We didn't find any harmful effects of women diagnosed with breast cancer consuming soy in terms of mortality," said study leader Dr. Fang Fang Zhang. She's an assistant professor of epidemiology at Tufts University's Friedman School of Nutrition Science and Policy in Boston. "Overall, consuming higher levels of soy is associated with a 21 percent reduction in the risk of death compared to women who consumed soy at a lower level," she said. Concerns around soy's "risk/benefit" profile have arisen because the food has estrogen-like compounds called isoflavones. That's important, experts says, ... Read more

Related support groups: Hot Flashes, Breast Cancer, Menopausal Disorders, Postmenopausal Symptoms, Breast Cancer, Metastatic, Soy, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Bad Diet in Youth Might Raise Risk of Early Breast Cancer

Posted 2 Mar 2017 by Drugs.com

THURSDAY, March 2, 2017 – A poor diet while young may do more than just make it tough to fit into a pair of jeans: New research suggests it might also raise a younger woman's risk for breast cancer. "A diet high in sugar, refined carbohydrates, and red and processed meat makes it more likely that you may experience early onset breast cancer," said study senior author Karin Michels. She is chair of epidemiology at the UCLA Fielding School of Public Health, in Los Angeles. An unhealthy diet appeared to increase that risk by more than one-third, but the findings can't prove cause-and-effect, Michels said. "We are talking about a link or association," she noted. The study tracked data from more than 45,000 women enrolled in the Nurses' Health Study II. All of the women completed food frequency questionnaires about their teen and early adult diets, and were followed up for 22 years. The ... Read more

Related support groups: Obesity, Breast Cancer, Menopausal Disorders, Postmenopausal Symptoms, Breast Cancer, Metastatic, Perimenopausal Symptoms, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation

Diagnostic Mammograms Find More Cancers, and More False-Positives

Posted 28 Feb 2017 by Drugs.com

TUESDAY, Feb. 28, 2017 – Thanks to high-tech imaging, mammograms ordered when breast cancer is suspected are catching more tumors – but the percentage of false alarms is up, too, a new study finds. These so-called diagnostic mammograms are performed because of certain symptoms or other suspicious findings. They are not the same as routine screening mammograms, said the study's lead author, Brian Sprague. The new study found the breast cancer detection rate rose to nearly 35 per 1,000 diagnostic mammograms from 2007 to 2013. That's up from 25 per 1,000 noted in a 2005 report from the Breast Cancer Surveillance Consortium. This higher detection rate probably reflects the switch from film to digital technology, which permits identification of smaller lesions, said Sprague. He is associate professor of surgery at the University of Vermont College of Medicine. "About 99 percent" of exams ... Read more

Related support groups: Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Diagnosis and Investigation, Body Imaging

Exercise a Powerful Ally for Breast Cancer Survivors

Posted 21 Feb 2017 by Drugs.com

TUESDAY, Feb. 21, 2017 – For breast cancer survivors, exercise may help lower their chances of dying from the disease more than other healthy habits, a new review suggests. The Canadian researchers analyzed 67 published articles to see which habits made the most difference in reducing the risk of either breast cancer recurrence or death. Exercise came out on top, reducing the risk of breast cancer death by about 40 percent, said review author Dr. Ellen Warner, a medical oncologist at Sunnybrook Odette Cancer Centre and a professor at the University of Toronto. "It's similar to the magnitude of chemotherapy or hormone therapy," she said. "So, that's pretty powerful." However, the review did not prove that exercise causes breast cancer risk to drop. Besides exercise, the previous research looked at weight and weight gain, diet, smoking, alcohol and vitamin supplements. The new review ... Read more

Related support groups: Obesity, Weight Loss, Breast Cancer, Vitamin/Mineral Supplementation and Deficiency, Vitamin C, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Caltrate 600 with D, Breast Cancer - Palliative, Calcium/Vitamin D, Ascorbic Acid, Citracal + D, Protexin, Oysco 500 with D, Citracal Petites, Osteolytic Bone Metastases of Breast Cancer, Ester-C, Cecon, C/Rose Hips

'Cooling Caps' May Halt Chemo-Linked Hair Loss

Posted 14 Feb 2017 by Drugs.com

TUESDAY, Feb. 14, 2017 – Scalp cooling caps can help breast cancer patients save their hair from the ravages of chemotherapy, a pair of new studies suggests. More than half of women fitted with cooling caps kept their hair during chemotherapy in the world's first randomized clinical trial of the devices, said lead researcher Dr. Julie Nangia. She is an assistant professor and breast cancer expert with the Baylor College of Medicine in Houston. "The trial was stopped early because the device was so effective in the group that got the device," Nangia said. "In our study, half of women who used the scalp cooling device kept their hair, and in the control group there was zero percent hair retention. Everyone who didn't have the device lost their hair." A second study also found that the cooling caps could reduce hair loss, with two-thirds of patients losing half or less of their hair ... Read more

Related support groups: Cancer, Breast Cancer, Colorectal Cancer, Breast Cancer, Metastatic, Herceptin, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Tykerb, Perjeta, Kadcyla, Trastuzumab, Lapatinib, Pertuzumab, Ado-trastuzumab Emtansine

Good News for Older Women With Early Form of Breast Cancer

Posted 27 Jan 2017 by Drugs.com

FRIDAY, Jan. 27, 2017 – Older women treated for a very early form of breast cancer, called ductal carcinoma in situ (DCIS), do not have an overall increased risk of early death compared to their peers, a new study finds. "Being diagnosed with DCIS can be extremely distressing, and research indicates that many women overestimate the risks involved and are confused about treatment. This study should provide reassurance that a diagnosis of DCIS does not raise the risk of dying," said Dr. Lotte Elshof. She is an epidemiologist at the Netherlands Cancer Institute in Amsterdam. Elshof was to present the findings Friday at the European Cancer Congress in Amsterdam. According to the National Breast Cancer Foundation, DCIS "is a noninvasive cancer where abnormal cells have been found in the lining of the breast milk duct. The atypical cells have not spread outside of the ducts into the ... Read more

Related support groups: Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Fibrocystic Breast Disease, Breast Conditions

Half Report Severe Side Effects From Breast Cancer Therapy

Posted 24 Jan 2017 by Drugs.com

TUESDAY, Jan. 24, 2017 – About half of early stage breast cancer patients experience severe side effects from their treatment, a new study finds. "It's in patients' best interest to receive their treatments on time and on schedule, whenever possible, to give them the best possible outcome," said study author Dr. Steven Katz. He's professor of health management and policy at the University of Michigan. "Unscheduled care for toxicities [side effects] – including clinic visits, emergency department visits and hospital stays – are expensive, inconvenient and disruptive to both doctors and patients. We need to avoid them whenever possible," Katz said in a university news release. For the study, researchers surveyed almost 2,000 early stage breast cancer patients an average of seven months after diagnosis. The women were asked to rate the severity of seven common treatment side effects: ... Read more

Related support groups: Surgery, Breast Cancer, Fluorouracil, Efudex, Carac, Breast Cancer, Metastatic, Herceptin, Taxol, Breast Cancer - Adjuvant, Taxotere, Carboplatin, Cytoxan, Cyclophosphamide, Paclitaxel, Breast Cancer, Prevention, Adriamycin, Breast Cancer - Palliative, Fluoroplex, Doxorubicin, Surgical Prophylaxis

Could Grilled, Smoked Meats Lower Survival After Breast Cancer?

Posted 19 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 18, 2017 – Research has suggested that diets high in barbecued, grilled and smoked meats could increase the risk of breast cancer. Now, a new study finds these cooking methods may also lower survival after a breast cancer diagnosis. The study involved more than 1,500 women who had been diagnosed with the cancer in 1996 and 1997. The study participants were followed for nearly 20 years. Eating lots of grilled, barbecued or smoked meat before their cancer diagnosis was linked with a 23 percent increased risk of dying from any cause during the follow-up period compared with low intake, the researchers said. And continuing to eat lots of meat cooked in this fashion after breast cancer seemed to increase those odds, the findings suggested. Beef, pork and lamb, in particular, were singled out as potentially troublesome. Grilling, smoking and cooking meats at high temperatures ... Read more

Related support groups: Obesity, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

'Chemo Brain' Lasts for Months in Many Breast Cancer Survivors

Posted 11 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 11, 2017 – "Chemo brain" – the mental fog common after breast cancer treatment – can persist for six months, new research shows. The finding comes from one of the largest studies to date to look at chemotherapy-related thinking problems that plague many women treated for breast cancer. Those problems can include memory lapses, attention issues and difficulty processing information. When researchers compared hundreds of U.S. women six months after chemotherapy ended with hundreds of healthy women, they found more than one-third of the chemotherapy group had a decline in thinking scores versus less than 15 percent of the others. "The bottom line is, this is a real problem, patients are having difficulties and we need to acknowledge it is one of the difficulties of treatment," said Dr. Patricia Ganz. Ganz is director of cancer prevention and control research at the ... Read more

Related support groups: Cancer, Provera, Depo-Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Zoladex, Breast Cancer, Metastatic, Anastrozole, Letrozole, Evista, Megestrol, Megace, Afinitor, Herceptin, Aromasin

Many With Breast Cancer Unnecessarily Choose Double Mastectomy: Study

Posted 22 Dec 2016 by Drugs.com

WEDNESDAY, Dec. 21, 2016 – Many women with early stage breast cancer choose to have their healthy opposite breast removed, even when there are no medical indications that such a step is necessary, a new survey finds. That's especially true when the surgeon doesn't offer a recommendation either way, the researchers said. "We are seeing that one in six breast cancer patients are choosing bilateral mastectomy when this aggressive procedure is not going to benefit them in terms of survival," said Dr. Reshma Jagsi. Jagsi, who led the study, is a professor and deputy chair of radiation oncology at the University of Michigan School of Medicine. Cancer specialists say no compelling evidence suggests a survival advantage for most patients to chose a double mastectomy. Also, the risk of getting cancer in the opposite healthy breast is low for most patients, they note. However, after actress ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Minority Women Less Likely to Get Breast Cancer Screening

Posted 16 Dec 2016 by Drugs.com

FRIDAY, Dec. 16, 2016 – Black and Hispanic women are less likely than white women to be screened for breast cancer, a large review finds. Screening rates for Asian/Pacific Islander and white women were similar, the research showed. The analysis of 39 studies including 6 million women was published Dec. 16 in the Journal of the American College of Radiology. "Not only do black and Hispanic women get screened less than white women, but disparities also persist in two age groups: women who are 40 to 65 years old, and 65 and older," study author Dr. Ahmed Ahmed said in a journal news release. "These findings are important; it's evident that more work needs to be done to ensure that all eligible women have access to this preventive screening tool," added Ahmed. He's a postdoctoral fellow researcher at the Mayo Clinic in Rochester, Minn. A great deal of effort has gone into finding racially ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Body Imaging

Angelina Jolie's Mastectomies Tied to Rise in Genetic Testing

Posted 15 Dec 2016 by Drugs.com

THURSDAY, Dec. 15, 2016 – After actress Angelina Jolie had both breasts removed because she faced a heightened risk for breast cancer, there was a spike in the number of women who were tested for the genes that raise that risk. But, there was no corresponding increase in mastectomy rates, researchers report. Jolie's 2013 announcement about her decision was delivered in an editorial in The New York Times. "That editorial was widely shared on social media, and we saw a jump in BRCA gene testing the day after the editorial," said lead researcher Sunita Desai. She is a fellow in the department of health care policy at Harvard Medical School in Boston. "In the two weeks after the editorial, we found a 64 percent jump in gene testing, compared with gene testing in the two weeks before the editorial, and a $13.5 million increase in spending on BRCA testing in this population," she said. "The ... Read more

Related support groups: Breast Cancer, Arimidex, Femara, Breast Cancer, Metastatic, Anastrozole, Letrozole, Aromasin, Exemestane, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation, Testolactone, Teslac

Beating Breast Cancer But Still Paying a Price

Posted 15 Dec 2016 by Drugs.com

THURSDAY, Dec. 15, 2016 – Women who survive breast cancer often experience lingering physical and emotional symptoms that go untreated, new research suggests. Ninety-two percent of long-term breast cancer survivors report at least three untreated symptoms for which they need assistance, according to the study. The most common unmet needs are achy joints, fatigue and weight gain – each affecting about one in four survivors in the study. Survivors living with more unmet needs are also more likely to experience anxiety and depression, the study found. Although the study involved just over 100 mostly white and college-educated women at one cancer center, the findings may be important for the nation's 2.8 million breast cancer survivors, the study authors suggest. When you extrapolate these results to the larger population of survivors, "it gets a lot worse very quickly," said lead author ... Read more

Related support groups: Anxiety and Stress, Breast Cancer, Psychiatric Disorders, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Loneliness May Sabotage Breast Cancer Survival: Study

Posted 12 Dec 2016 by Drugs.com

MONDAY, Dec. 12, 2016 – Loneliness may impede long-term breast cancer survival, a new study suggests. In the years after treatment, women who don't have strong social ties are more likely to have their cancer return or die from it than women with friends and a support network, the researchers found. Reviewing data on nearly 10,000 breast cancer patients, the researchers linked isolation with a 40 percent higher risk of cancer recurrence compared to socially connected women. These solitary women also had a 60 percent increased risk of dying from breast cancer and a 70 percent increased risk of dying from any cause, the study found. The results weren't unexpected, the researchers said. "It is well established that women generally and those with breast cancer with greater social ties have a lower risk of death overall," said lead researcher Candyce Kroenke. She's with Kaiser Permanente's ... Read more

Related support groups: Depression, Anxiety, Anxiety and Stress, Breast Cancer, Breast Cancer, Metastatic, Psychiatric Disorders, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Page 1 2 3 4 5 6 7 8 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer

Related Drug Support Groups

Lupron, tamoxifen, Femara, letrozole, Herceptin, Taxol, paclitaxel, leuprolide, epirubicin, view more... trastuzumab, Tamoxifen Hexal, Nolvadex, Tamoxen, Pharmorubicin RDF, Pharmorubicin PFS, Tamosin, Genox, Tamone, Onxol, Ellence, Soltamox, Emblon, Tamofen, Nolvadex D